Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene.
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
Business Wire
3d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
12h
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Dockworkers launch strike
Pete Rose dies at 83
Helene wreaks havoc
NBA Hall of Famer dies
Medical records breached
Tony-winning star dies
Explosive devices found
Wausau drop box replaced
CA bans legacy admissions
Settlement checks delayed
Hand count rule challenged
More troops to Middle East
NH voter ID law challenged
Lose 'superhero' trademark
194K Jeep SUVs recalled
Asylum restrictions extended
Mich. nuclear plant to restart
To lay off 2,900 employees
SpaceX Falcon 9 grounded
'Sing Sing' actor exonerated
Settles data breach cases
Sells stake in DirecTV
To sue Google, Samsung
Israel announces operation
Comer subpoenas Mayorkas
Signals more rate cuts
Feedback